Edwards Lifesciences Corporation Stock price
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.85 USD | +0.58% | +2.22% | +21.77% |
Financials (USD)
Sales 2024 * | 6.52B | Sales 2025 * | 7.17B | Capitalization | 55.83B |
---|---|---|---|---|---|
Net income 2024 * | 1.62B | Net income 2025 * | 1.82B | EV / Sales 2024 * | 8.22 x |
Net cash position 2024 * | 2.23B | Net cash position 2025 * | 3.62B | EV / Sales 2025 * | 7.29 x |
P/E ratio 2024 * |
34.6
x | P/E ratio 2025 * |
30.9
x | Employees | 19,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.6% |
Latest transcript on Edwards Lifesciences Corporation
1 day | +0.58% | ||
1 week | +0.77% | ||
Current month | +9.40% | ||
1 month | +7.84% | ||
3 months | +20.74% | ||
6 months | +26.84% | ||
Current year | +21.77% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 14-12-31 | |
Chairman | 71 | 99-12-31 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 16-07-04 |
Director/Board Member | 67 | 14-11-12 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.46% | 43 M€ | +3.51% | - | |
2.34% | 18 M€ | +4.89% | - | |
2.13% | 6 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 92.85 | +0.58% | 2,899,689 |
24-03-15 | 92.31 | -1.12% | 5,700,263 |
24-03-14 | 93.36 | +0.46% | 5,066,707 |
24-03-13 | 92.93 | +2.22% | 7,036,488 |
24-03-12 | 90.91 | +0.09% | 2,323,870 |
Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.77% | 55.51B | |
+9.28% | 223B | |
+8.70% | 184B | |
+16.38% | 140B | |
+16.31% | 97.17B | |
+5.51% | 67.87B | |
+0.85% | 49.49B | |
+5.08% | 43.22B | |
+17.19% | 40.71B | |
+11.01% | 27.91B |